Cyclosporin_NN
A_NN
inhibits_VBZ
early_JJ
mRNA_NN
expression_NN
of_IN
G0\/G1_NN
switch_NN
gene_NN
2_CD
-LRB-_-LRB-
G0S2_NN
-RRB-_-RRB-
in_IN
cultured_VBN
human_JJ
blood_NN
mononuclear_JJ
cells_NNS
._.

Cyclosporin_NN
A_NN
-LRB-_-LRB-
CsA_NN
-RRB-_-RRB-
may_MD
achieve_VB
its_PRP$
immunosuppressive_JJ
effects_NNS
by_IN
inhibiting_VBG
the_DT
calcium_NN
-_:
and_CC
calmodulin-dependent_JJ
phosphatase_NN
calcineurin_NN
which_WDT
is_VBZ
required_VBN
for_IN
activation_NN
of_IN
target_NN
genes_NNS
by_IN
members_NNS
of_IN
the_DT
NFAT_NN
-LRB-_-LRB-
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
-RRB-_-RRB-
transcription_NN
factor_NN
family_NN
._.

Among_IN
these_DT
target_NN
genes_NNS
is_VBZ
the_DT
gene_NN
encoding_VBG
interleukin-2_NN
-LRB-_-LRB-
IL2_NN
-RRB-_-RRB-
,_,
a_DT
cytokine_NN
facilitating_VBG
progression_NN
through_IN
the_DT
G1_NN
phase_NN
of_IN
the_DT
cell_NN
cycle_NN
._.

However_RB
,_,
IL2_NN
does_VBZ
not_RB
reverse_VB
CsA_NN
inhibition_NN
,_,
suggesting_VBG
that_IN
at_IN
least_JJS
one_CD
other_JJ
NFAT-sensitive_JJ
gene_NN
may_MD
be_VB
involved_VBN
._.

The_DT
human_JJ
G0\/G1_NN
switch_NN
gene_NN
,_,
G0S2_NN
,_,
has_VBZ
potential_JJ
NFAT-binding_JJ
sites_NNS
in_IN
the_DT
5_CD
'_''
flank_NN
and_CC
encodes_VBZ
a_DT
small_JJ
basic_JJ
potential_JJ
phosphoprotein_NN
of_IN
unknown_JJ
function_NN
._.

Using_VBG
a_DT
sensitive_JJ
,_,
reverse_JJ
transcription-polymerase_NN
chain_NN
reaction_NN
-LRB-_-LRB-
RT-PCR_NN
-RRB-_-RRB-
assay_NN
,_,
G0S2_NN
mRNA_NN
levels_NNS
were_VBD
assayed_VBN
in_IN
cultured_VBN
blood_NN
mononuclear_JJ
cells_NNS
._.

Freshly_RB
isolated_VBN
cells_NNS
contain_VBP
high_JJ
levels_NNS
of_IN
G0S2_NN
mRNA_NN
which_WDT
rapidly_RB
decline_VBP
._.

This_DT
``_JJ
spontaneous_JJ
stimulation_NN
''_NN
is_VBZ
also_RB
noted_VBN
with_IN
some_DT
other_JJ
G0S_NN
genes_NNS
and_CC
has_VBZ
been_VBN
attributed_VBN
to_TO
some_DT
aspect_NN
of_IN
the_DT
isolation_NN
procedure_NN
._.

In_IN
cells_NNS
that_WDT
have_VBP
been_VBN
preincubated_VBN
to_TO
lower_JJR
mRNA_NN
levels_NNS
,_,
there_EX
is_VBZ
a_DT
transient_JJ
increase_NN
in_IN
G0S2_NN
mRNA_NN
,_,
peaking_VBG
between_IN
1-2_CD
h_NN
,_,
in_IN
response_NN
to_TO
Concanavalin-A_NN
-LRB-_-LRB-
ConA_NN
-RRB-_-RRB-
,_,
or_CC
to_TO
the_DT
combination_NN
of_IN
phorbol_NN
ester_NN
-LRB-_-LRB-
TPA_NN
-RRB-_-RRB-
,_,
and_CC
the_DT
calcium_NN
ionophore_NN
,_,
ionomycin_NN
._.

Both_PDT
these_DT
responses_NNS
are_VBP
inhibited_VBN
by_IN
CsA_NN
._.

Our_PRP$
results_NNS
suggest_VBP
that_IN
G0S2_NN
expression_NN
is_VBZ
required_VBN
to_TO
commit_VB
cells_NNS
to_TO
enter_VB
the_DT
G1_NN
phase_NN
of_IN
the_DT
cell_NN
cycle_NN
,_,
and_CC
that_IN
,_,
while_IN
not_RB
excluding_VBG
other_JJ
possible_JJ
targets_NNS
,_,
early_JJ
inhibition_NN
of_IN
G0S2_NN
expression_NN
by_IN
CsA_NN
may_MD
be_VB
important_JJ
in_IN
achieving_VBG
immunosuppression_NN
._.

G0S2_NN
may_MD
be_VB
of_IN
value_NN
as_IN
a_DT
reporter_NN
gene_NN
for_IN
analyzing_VBG
the_DT
mechanism_NN
of_IN
action_NN
of_IN
CsA_NN
and_CC
its_PRP$
influence_NN
on_IN
the_DT
positive_JJ
and_CC
negative_JJ
selection_NN
of_IN
lymphocytes_NNS
in_IN
response_NN
to_TO
self_NN
and_CC
not-self_JJ
antigens_NNS
._.

